CD4+ T-cell recognition of diverse clade B HIV-1 isolates

AIDS

Volumn 11, Issue 3, 1997, Pages 281-288

  Fernandez, Maria H ^a   Fidler, Sarah J ^a   Pitman, Richard J ^a   Weber, Jonathan N ^a   Rees, Ann D M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

CD4+ T cell reactivity; Cellular immunity; Clade B and D T cell cross reactivity; Heterogeneity; V3 loop; Vaccine

Indexed keywords

CD4 ANTIGEN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; SYNTHETIC PEPTIDE;

ANTIGEN RECOGNITION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CLONE; MALE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINE PRODUCTION; VIRUS ISOLATION;

AIDS VACCINES; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CLONE CELLS; DRUG DESIGN; EPITOPE MAPPING; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031028383     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199703110-00004     Document Type: Article

References (37)

1. Moore JP, Nara PL : The role of the V3 loop in HIV infection. AIDS 1991, 5:521-533.
2. Nara PL, Garrity RR, Goudsmit J: Neutralisation of HIV-1: a paradox of humoral proportions. FASEB J 1991, 5:2437-2455,
3. Nixon DF, McMicheal AJ: Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 1991, 5:1049-1059.
4. Panteleo G, Demarest JF, Soudeyns H, et al.: Major expansion of CD8+ T-cells with predominant Vβ usage during the primary response to HIV-1. Nature 1994, 370:463-467.
5. Bennick JR, Doherty PC: Different rules govern help for cytotoxic T cells and B cells. Nature 1978, 276:829-831.
6. Husmann LA, Bevan MJ: Co-operation between helper T cells and cytotoxic T lymphocytes precursors. Ann NY Acad Sci 1988, 532:158-169.
7. Clarke EA, Ledbetter JA: How B and T cells talk to each other. Nature 1994, 367:425-428.
8. Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA: Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs. J Immunol 1994, 152:549-556.
9. Johnson RP, Trocha A, Buchanen TM, Walker BD: Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J Exp Med 1992, 175:961-971.
10. Siliciano RF, Lawton T, Knall C, et al.: Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 1988, 54:551-575.
11. Fernandez MH, Faith A, Higgins JA, Weber J, Rees ADM: The effect of a single amino acid substitution within the V 3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition. Immunology 1995, 85:176-183.
12. Brown LR, Nygard NR, Graham MB: Recognition of the influenza hemagglutinin by class II-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. J Immunol 1991, 147:2677-2684.
13. De Magistris MT, Romano M, Bartolini A, Rappuoli R, Tagliabue LA: Human T cell clones define the S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map. J Exp Med 1989, 169:1519-1532.
14. Nowak MA, Bangham CRM: Population dynamics of immune responses to persistent viruses. Science 1996, 272:74-79
15. Myers G, Korber B, Wain-Hobson S, Smith RF, Pavlakis GN: Human Retrovirus and AIDS, Los Alamos: Theoretical Biology and Biophysics, Los Alamos National Laboratory; 1994.
16. Clerici M, Giorgi JV, Chou CC, et al.: Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992, 165:1012-1019.
17. Wahren B, Rosen J, Sandstrom F, Mathieson I, Modrow S, Wigzell H: HIV-1 peptides induce a proliferative response from infected persons. J Acquir Immune Defic Syndr 1989, 4:448-456.
18. Mutch D, Underwood J, Geysen M, Rodda S: Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognised by HIV-1 seropositive and by low-risk HIV-1 seronegative individuals. J Acquir Immune Defic Syndr 1994, 7:879-890.
19. Rallo S, Sitz KV, Scherer A, et al.: CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognise different epitopes within the V3 loop. J Acquir Immune Defic Syndr 1996, 11:128-136.
20. Fvavold BD, Sloan-Lancaster J, Allen PM: Tickling the TCR: selective T-Cell functions stimulated by altered peptide ligands. Immunol Today 1993, 14:602-609.
21. Fidler S, Dorrell L, Ball S, et al.: An early antigen-presenting cell defect in HIV-1 infected patients correlates with CD4 dependency in human T-cell clones. Immunology 1996, 89:46-53.
22. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41 (RR-17):1-19.
23. Bieniasz PD, Ariyoshi K, Bourelly MAD, et al.: Variable relationship between proviral DNA and infectious virus titre in the peripheral blood monomuclear cells of HIV-1-infected individuals. AIDS 1993, 7:803-806.
24. Holmes P, Zhang LQ, Simmonds P, Ludlum CA, Brown AJL: Convergent and divergent sequence evolution in the surface glycoprotein of HIV-1 within a single infected patient. Proc Natl Acad Sci USA 1992, 89:4836-4839.
25. Hutmant E, Stahl S, Hornes E, Uhlen M: Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 1989, 17:4937-4946.
26. Simpson EH: Measurement of diversity. Nature 1994, 168:688-690.
27. Fechler RI, Ronchese F, Braunstein NS, Germain RN: I-A restricted T cell antigen recognition. Analysis of the roles of Aα and Aβ using DNA-mediated gene transfer. J Exp Med 1986, 163:678-690.
28. Berzofsky JA, Pendleton CD, Clerici M, et al.: Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types. J Clin Invest 1991, 88:876-884.
29. Hammond SA, Obah E, Stanhope P, et al.: Characterisation of a conserved T cell epitope in HIV-1 gp41 recognised by vaccine induced human cytolytic T cells. J Immunol 1991, 146:1470-1477.
30. Hammond SA, Bollinger RC, Stanhope PE, et al.: Comparative clonal analysis human immunodeficiency virus type 1 (HIV)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunised with candidate HIV-1 vaccines. J Exp 1992, 176:1531-1542.
31. Adorini L, Appella E, Doria G, Nagy ZA: Mechanisms influencing the immunodominance of T cell determinants. J Exp Med 1988, 168:209-219.
32. Demotz S, Matricardi PM, Irie C, Panina P, Lanzavecchia A, Corradin G: Processing of tetanus toxin by human antigen presenting cells: evidence for donor and epitope-specific processing pathways. J Immunol 1989, 12:3881-3886.
33. Jardetsky TS, Gorga JC, Busch R, Rothhard J. Strominger JL, Wiley DC: Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J 1990, 9:1797-1803.
34. Hammer J, Takacs B, Sinigaglia F: Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med 1992, 176:1007-1013.
35. O'Sullivan D, Arrhenius T, Sidney J, et al.: On the interaction of promiscuous antigenic peptides with different DR alleles. J Immunol 1991, 147:2663-2669.
36. Goudsmit J, Back NT, Nara PL: Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development, FASEB J 1991, 5:2427 2436.
37. Cheinsong-Popov R, Lister S, Callow D, et al.: Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. AIDS Res Hum Retrovirus 1994, 11:1379-1385.